Precision Medicine News and Research

RSS

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

While cancer treatment advances are being made in the areas of precision medicine and immunotherapy, a unique combination of traditional therapies can also provide some cancer patients a treatment option that may provide significant benefit.

11 Feb 2018

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

9 Feb 2018

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.

8 Feb 2018

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

A new partnership in Leeds has been agreed to evaluate the benefits of a diagnostic blood test which can help predict whether someone is likely to develop type 2 diabetes.

7 Feb 2018

Scientists develop new system to match genetic anomalies with precision medicine treatments

A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers.

6 Feb 2018

German researchers find way to accurately differentiate prostate cancer from benign tissue

Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine.

6 Feb 2018

Mitochondrial DNA may play more important role in metastatic cancer than previously thought

DNA found in the mitochondria may play a more significant role in metastatic cancer than originally thought.

6 Feb 2018

Researchers develop new method for producing personalized medicine

For the last 100 years, researchers have constantly pushed the boundaries for our knowledge about medicine and how different bodies can respond differently to it.

2 Feb 2018

RCSI to lead major study for finding new ways to treat colorectal cancer patients

RCSI is leading an international team of scientists on a major research study “COLOSSUS” which aims to provide new and more effective ways to classify and treat patients with colorectal cancer.

2 Feb 2018

New modular platform offers robust biological approach that targets endless number of diseases

The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.

1 Feb 2018

Researchers win $6.5 million NIH grant to personalize diagnosis and treatment of psoriasis

An experienced interdisciplinary team of psoriasis and computational researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center has received a $6.5M, 5-year grant from the National Institute of Arthritis, Musculoskeletal and Skin Diseases.

29 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

UTokyo enters into agreement for developing personalized cancer vaccine

The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.

25 Jan 2018

New powerful database to help prevent asthma in children

Imagine a world where allergies, asthma and related chronic diseases are rare. Better yet, imagine a world where these conditions can be prevented before they even develop.

25 Jan 2018

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

A new study published yesterday in the Journal of the National Cancer Institute suggests that, in comparison with just screening women who are at high risk of carrying breast and ovarian cancer gene mutations, screening the entire population for these mutations will be more cost-effective.

18 Jan 2018

New precision medicine approach for metastatic pancreatic cancer

A three-year grant has been awarded to fund a phase 1b clinical trial of a precision medicine approach to treating metastatic pancreatic cancer.

18 Jan 2018

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute.

18 Jan 2018

Study to test new precision medicine approach for metastatic pancreatic cancer

The Lustgarten Foundation has awarded Columbia University's Herbert Irving Comprehensive Cancer Center a three-year grant, as part of its Translational Clinical Program, to test a new precision medicine approach to the treatment of metastatic pancreatic cancer.

18 Jan 2018

Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies

Immunologists and oncologists are harnessing the body's immune system to fight cancers and other diseases with adoptive cell transfer techniques. In a normal immune response, a type of white blood cell known as T cells are instructed by another kind of immune cell called an antigen-presenting cell (APC) to expand their numbers and stay alive.

15 Jan 2018

Experts look for ways to standardize treatments for pediatric rheumatic diseases

Pediatric rheumatic diseases are a varied group of rare diseases including juvenile forms of arthritis, lupus, fibromyalgia, and other conditions.

15 Jan 2018

Precision Medicine News and Research

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

New partnership to evaluate effectiveness of diagnostic blood test for type 2 diabetes

Scientists develop new system to match genetic anomalies with precision medicine treatments

German researchers find way to accurately differentiate prostate cancer from benign tissue

Mitochondrial DNA may play more important role in metastatic cancer than previously thought

Researchers develop new method for producing personalized medicine

RCSI to lead major study for finding new ways to treat colorectal cancer patients

New modular platform offers robust biological approach that targets endless number of diseases

Researchers win $6.5 million NIH grant to personalize diagnosis and treatment of psoriasis

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

UTokyo enters into agreement for developing personalized cancer vaccine

New powerful database to help prevent asthma in children

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

New precision medicine approach for metastatic pancreatic cancer

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

Study to test new precision medicine approach for metastatic pancreatic cancer

Researchers use immune-mimicking biomaterial scaffolds to fast track T cell therapies

Experts look for ways to standardize treatments for pediatric rheumatic diseases

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News